Vetherapy

San Francisco, United States Founded: 2015 • Age: 11 yrs
Provider of stem cell therapies for pets

About Vetherapy

Vetherapy is a company based in San Francisco (United States) founded in 2015 by Pedro Carvalho and Fernanda Berti. Vetherapy has raised $250 thousand across 3 funding rounds from investors including European Union, EIC Fund and IndieBio. Vetherapy offers products and services including Wound Healing Hydrogel, Stem Cells, and Stem Cell-derived solutions. Vetherapy operates in a competitive market with competitors including Gallant, eQcell, Bioceltix, RevaTis and J-ARM, among others.

  • Headquarter San Francisco, United States
  • Founders Pedro Carvalho, Fernanda Berti
  • Sectors
    Healthcare
  • Phone
    โ€ขโ€ขโ€ขโ€ข โ€ขโ€ขโ€ขโ€ข
  • Website vetherapy.co
  • Social LinkedIn X Facebook
Key Metrics
  • Total Equity Funding
    $250K (USD)

    in 3 rounds

  • Latest Funding Round
    $54.68K (USD), Grant

    Sep 2019

  • Investors

Products & Services of Vetherapy

Vetherapy offers a comprehensive portfolio of products and services, including Wound Healing Hydrogel, Stem Cells, and Stem Cell-derived solutions.

Wound Healing Hydrogel
Therapy Product

Hydrogel for accelerating wound healing in pets using stem cells.

Stem Cells
Regenerative Therapy

Stem cell treatments for complex diseases in pets.

Stem Cell-derived solutions
Biotech Solutions

Derived therapies for various pet health challenges.

Funding Insights of Vetherapy

Vetherapy has successfully raised a total of $250K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $54.68 thousand completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $250,000
  • Total Rounds 3
  • Last Round Grant โ€” $54,684
  • First Round $250,000

    (Jan 2018)

  • Investors Count 3

All 3 funding rounds of Vetherapy with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2019$54,684Grantโ€“โ€“
May 2019$56,002Grantโ€“โ€“
Jan 2018$250,000Seedโ€“IndieBio
โ€“
Valuation history

3 investors in total: 3 institutional.

Investors in Vetherapy

Vetherapy has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, EIC Fund and IndieBio.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
–eicfund.euBrussels, Belgium
Biotech startups are accelerated through IndieBio's focused programs.
–indiebio.coSan Francisco, United States
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Vetherapy

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Vetherapy

4 people are tracked at Vetherapy (4 in leadership).

NameRoleGroup
Pedro Carvalho
Co-Founder & CEOLeadership
Fernanda Berti
Co-Founder & CSOLeadership
Fernanda Vieira Berti
Co-Founder & CSOLeadership
Alessandra Zonari
CTOLeadership
Premium access

Complete people profiles for Vetherapy

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Vetherapy

3 dated milestones of Vetherapy across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Vetherapy is founded.
  2. Funding First funding round of $250K.
  3. Funding Latest funding round, Grant, of $55K.

Competitors of Vetherapy

Vetherapy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gallant, eQcell, Bioceltix, RevaTis and J-ARM, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
gallant.com2018Los Angeles, United States$61.46M–
Stem cell storage for canine regenerative therapy is offered.
eqcell.com2010Guelph, Canada$4.6M8
Stem cell therapies for animal health are developed.
bioceltix.com2017Wroclaw, Poland––
Developer of drugs for veterinary therapy
revatis.com2013Luxemburg, United States––
Undifferentiated muscle-derived stem cells are obtained via patented micro-biopsy technology.
j-arm.biz2006Osaka, Japan––
Developer of lymphocyte therapy and stem cell therapy for dogs and cats
vetbiobank.com2011–$450,237–
Veterinary regenerative medicine
vetstem.com2002Poway, United States––
Regenerative stem cell therapy for arthritis and injuries in dogs, cats, and horses.
nupsala.com2012Melton Mowbray, United Kingdom$192,59516
Veterinary pharmaceuticals and products are supplied alongside educational resources.
Premium access

Detailed competitors of Vetherapy

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to Vetherapy

10 companies that operate in the same segment as Vetherapy (Veterinary Digital Health), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Practice and prescription management software is provided for veterinary professionals.
2010Portland, Oregon, United StatesUSD 291.64 M––
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
2012Brussels, Brussels-capital Region, Belgium–––
Veterinary pharmacy services are delivered by VetSource to practices.
2005Portland, Oregon, United StatesUSD 81.25 M––
Animal health therapeutics are developed and supplied globally by Ceva.
1999Libourne, Nouvelle-aquitaine, FranceUSD 214.35 M––
Digital platform for pet insurance
2020Stockholm, SwedenUSD 114.08 M––
App based platform providing veterinary services and clinical management solutions for veterinarians
2018Beverly Hills, California, United StatesUSD 58.81 M––
Online client communication platform for veterinary doctors
2013San Diego, California, United StatesUSD 14.11 MUSD 14.38 M1
Virtual veterinary care is provided via an app platform.
2018Los Angeles, California, United StatesUSD 210 M–163
Comprehensive customer engagement platform for veterinary clinics is provided.
2015Austin, Texas, United StatesUSD 50.3 M––
Veterinary appointments are booked via an online platform.
2017Brooklyn, New York, United StatesUSD 243 M–64
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track โ€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • โœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • โœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • โœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Vetherapy

Vetherapy was founded in 2015 and raised its 1st funding round 3 years after it was founded.

Vetherapy is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Pedro Carvalho is the current CEO of Vetherapy. They have also founded this company.

Vetherapy is a funded company, having raised a total of $250K across 3 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Jan 2018.

VR therapy is developing stem cell therapies for pets. The company is focused on inflammatory, auto-immune and neurologic diseases. The company provides stem cells for dogs, cats, and horses. The company has patented wound healing hydrogel, based on stem cell secretome, that helps in the regeneration of all the layers of the skin. The company has stem cell-derived solutions in the form of eye-drops and plasma solutions.

Vetherapy's top competitors include Gallant, Bioceltix and eQcell.

Vetherapy offers Wound Healing Hydrogel, Stem Cells, and Stem Cell-derived solutions.

Vetherapy has 3 investors. Key investors include European Union, EIC Fund, and IndieBio.

Explore millions of companies โ€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals โ€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available